Telemedicine's role in transforming healthcare delivery in the pharmaceutical industry: A systematic review

Abstract

Telemedicine has emerged as a pivotal technology in transforming healthcare delivery, particularly within the pharmaceutical industry. This systematic review aims to evaluate the extent of telemedicine's impact, its applications, and the challenges it faces in this sector. By synthesizing data from peer-reviewed articles, reports, and case studies published up to 2023, this study adopts a comprehensive methodology to assess telemedicine's role in pharmaceutical care, patient management, and drug delivery systems. Key findings indicate that telemedicine significantly enhances patient access to pharmaceutical care, especially in remote and underserved areas. It facilitates real-time patient-pharmacist consultations, remote monitoring, and personalized medication management, thereby improving medication adherence and patient outcomes. Moreover, telemedicine platforms have been instrumental in streamlining drug development processes and clinical trials through virtual patient engagement and remote data collection. However, the review also identifies several challenges, including regulatory hurdles, privacy concerns, and the need for technological standardization across the industry. Despite these obstacles, the potential of telemedicine to revolutionize healthcare delivery in the pharmaceutical industry is undeniable, offering a more patient-centered, efficient, and cost-effective model of care. Telemedicine represents a transformative force in the pharmaceutical industry, promising to reshape the landscape of healthcare delivery. Its continued integration and adoption hinge on addressing existing challenges and leveraging technological advancements to fully realize its potential benefits for patients and healthcare providers alike.